Ithaka Group LLC Acquires 868 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Ithaka Group LLC has increased its stake in Intuitive Surgical, Inc. by 2.1%, now holding 42,116 shares valued at approximately $20.9 million, making it their 9th largest position.
• Intuitive Surgical reported $2.44 billion in revenue for the latest quarter, surpassing estimates of $2.35 billion, along with an EPS of $2.19, exceeding analyst expectations.
• Several analysts have raised their price targets for Intuitive Surgical, with a consensus target of $595.95, indicating confidence in the company's growth potential.

Ithaka Group LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,116 shares of the medical equipment provider's stock after purchasing an additional 868 shares during the period. Intuitive Surgical accounts for about 4.3% of Ithaka Group LLC's holdings, making the stock its 9th biggest holding. Ithaka Group LLC's holdings in Intuitive Surgical were worth $20,859,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after buying an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after acquiring an additional 883 shares during the period. World Investment Advisors boosted its holdings in Intuitive Surgical by 97.4% in the 4th quarter. World Investment Advisors now owns 916 shares of the medical equipment provider's stock worth $478,000 after acquiring an additional 452 shares during the period. Peapack Gladstone Financial Corp grew its position in Intuitive Surgical by 3.0% in the fourth quarter. Peapack Gladstone Financial Corp now owns 13,476 shares of the medical equipment provider's stock valued at $7,034,000 after acquiring an additional 391 shares in the last quarter. Finally, Cerity Partners LLC raised its stake in shares of Intuitive Surgical by 16.7% during the fourth quarter. Cerity Partners LLC now owns 162,397 shares of the medical equipment provider's stock valued at $84,209,000 after purchasing an additional 23,222 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 7,893 shares of the stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the sale, the insider directly owned 13,187 shares in the company, valued at approximately $6,575,565.68. This trade represents a 37.44% decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,903 shares of company stock worth $7,932,778 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded down $2.94 during trading on Wednesday, reaching $474.06. 2,189,756 shares of the company's stock traded hands, compared to its average volume of 2,261,750. The stock has a market capitalization of $169.94 billion, a P/E ratio of 66.12, a price-to-earnings-growth ratio of 5.00 and a beta of 1.59. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a 50 day moving average of $521.43 and a 200-day moving average of $531.52.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.78 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Royal Bank Of Canada upped their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a research note on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. UBS Group lifted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. BTIG Research boosted their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Finally, Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.